Verrica Pharmaceuticals is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. YCANTH was recently approved by the FDA for molluscum contagiosum. Verrica is focused on changing the narrative around skin diseases and making treatment a more efficient process for both physicians and patients. YCANTH, our lead product, is a drug-device combination topical therapy that is provider administered, in-office therapy.